1.
A.Nazmi Calik
@ANazmiCalik
TAVI vs Surgery: 3-YearEvolut Low Risk
Low Risk pts
30% relative reduction (p = 0.051) for death
or disabling str… twitter.com/i/web/status/1…
Low Risk pts
30% relative reduction (p = 0.051) for death
or disabling str… twitter.com/i/web/status/1…
2.
A.Nazmi Calik
@ANazmiCalik
Tomorrow at the JC there is a lot to learn about DAPT in HBR & meta-analysis
DM for the link
@sicigise twitter.com/theCardioJC/st…
DM for the link
@sicigise twitter.com/theCardioJC/st…
3.
4.
5.
6.
7.
A.Nazmi Calik
@ANazmiCalik
TOP 3 #GeneralCardiology
This week:
Hypertension and oral contraceptive use
“Moderate” aortic stenosis
Re… twitter.com/i/web/status/1…
This week:
Hypertension and oral contraceptive use
“Moderate” aortic stenosis
Re… twitter.com/i/web/status/1…
Retweet of status by @rladeiraslopes
A.Nazmi Calik
@ANazmiCalik
Have you seen our latest INOCA Newsletter yet? Here's a glimpse of it, just for you!
Click here to see the full… twitter.com/i/web/status/1…
Click here to see the full… twitter.com/i/web/status/1…
Retweet of status by @InocaInternati1
A.Nazmi Calik
@ANazmiCalik
Free access
The year in cardiovascular medicine 2022:
The #Top10 papers in interventional cardiology… twitter.com/i/web/status/1…
The year in cardiovascular medicine 2022:
The #Top10 papers in interventional cardiology… twitter.com/i/web/status/1…
Retweet of status by @EAPCIPresident
A.Nazmi Calik
@ANazmiCalik
Brainstorming session in progress - looking back on #EuroPCR 2022 & preparing for 2023! #KeeponLearning… twitter.com/i/web/status/1…
Retweet of status by @PCRonline
A.Nazmi Calik
@ANazmiCalik
Hot Lines Alert #ESCCongress
DELIVER - Dapagliflozin in Mildly Reduced HF & HFpEF
INVICTUS - Rivaroxaban vs V… twitter.com/i/web/status/1…
DELIVER - Dapagliflozin in Mildly Reduced HF & HFpEF
INVICTUS - Rivaroxaban vs V… twitter.com/i/web/status/1…
8.
9.
10.
11.
A.Nazmi Calik
@ANazmiCalik
What an honour to participate in the #ESCCongress 2022 as a(n)
🟣 Chairperson/Faculty
Abstract presenter
🟠 Abstr… twitter.com/i/web/status/1…
🟣 Chairperson/Faculty
Abstract presenter
🟠 Abstr… twitter.com/i/web/status/1…
A.Nazmi Calik, MD, FESC
@ANazmiCalik
#EuroPCR 2022 Case Corners
Let's unveil ‘The giant mass invading the RCA’ together.
@PCRonline @mirvatalasnag… twitter.com/i/web/status/1…
Let's unveil ‘The giant mass invading the RCA’ together.
@PCRonline @mirvatalasnag… twitter.com/i/web/status/1…
A.Nazmi Calik, MD, FESC
@ANazmiCalik
#ACC22 Clinical Trials :
Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrel… twitter.com/i/web/status/1…
Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrel… twitter.com/i/web/status/1…
Retweet of status by @PCRonline
A.Nazmi Calik, MD, FESC
@ANazmiCalik
Watch theof this #PCRwebinar to learn how the work of the #HeartTeam has been affected by recently-updated VHD gui… twitter.com/i/web/status/1…
Retweet of status by @PCRonline
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
